|
2020-12-11 |
2020-12-09 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
2,793
-49.7%
79.69
222,574
USD
|
2,793
-49.7%
|
79.69
|
222,574
USD
|
|
|
2020-11-17 |
2020-11-16 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
7,603
-57.5%
86.57
658,192
USD
|
7,603
-57.5%
|
86.57
|
658,192
USD
|
|
|
2020-11-17 |
2020-11-13 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
13,282
-70.3%
83.82
1,113,318
USD
|
13,282
-70.3%
|
83.82
|
1,113,318
USD
|
|
|
2020-11-12 |
2020-11-10 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
6,000
-51.6%
81.57
489,420
USD
|
6,000
-51.6%
|
81.57
|
489,420
USD
|
|
|
2020-11-06 |
2020-11-05 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
3,589
-39.0%
79.87
286,653
USD
|
3,589
-39.0%
|
79.87
|
286,653
USD
|
|
|
2020-11-06 |
2020-11-04 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
3,434
-37.9%
79.89
274,351
USD
|
3,434
-37.9%
|
79.89
|
274,351
USD
|
|
|
2020-11-06 |
2020-11-04 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
139
-0.6%
80.00
11,120
USD
|
139
-0.6%
|
80.00
|
11,120
USD
|
|
|
2020-11-06 |
2020-11-04 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
2,481
-9.7%
80.00
198,481
USD
|
2,481
-9.7%
|
80.00
|
198,481
USD
|
|
|
2020-10-20 |
2020-10-16 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
183
-3.2%
79.87
14,616
USD
|
183
-3.2%
|
79.87
|
14,616
USD
|
|
|
2020-10-07 |
2020-10-07 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,500
-6.1%
78.50
117,753
USD
|
1,500
-6.1%
|
78.50
|
117,753
USD
|
|
|
2020-10-07 |
2020-10-06 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
4,778
-17.2%
78.50
375,094
USD
|
4,778
-17.2%
|
78.50
|
375,094
USD
|
|
|
2020-10-07 |
2020-10-05 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
14,637
-38.9%
78.51
1,149,110
USD
|
14,637
-38.9%
|
78.51
|
1,149,110
USD
|
|
|
2020-06-10 |
2020-06-08 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,415
-5.8%
78.50
111,078
USD
|
1,415
-5.8%
|
78.50
|
111,078
USD
|
|
|
2020-05-19 |
2020-05-15 |
B
Purchase
|
MURRAY JAMES E
President and COO
Officer
|
4,500
+inf%
67.63
304,317
USD
|
4,500
+inf%
|
67.63
|
304,317
USD
|
|
|
2020-01-03 |
2020-01-02 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
200
-1.0%
78.53
15,706
USD
|
200
-1.0%
|
78.53
|
15,706
USD
|
|
|
2019-12-31 |
2019-12-30 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
104
-0.5%
78.50
8,164
USD
|
104
-0.5%
|
78.50
|
8,164
USD
|
|
|
2019-12-30 |
2019-12-27 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
606
-2.9%
78.54
47,597
USD
|
606
-2.9%
|
78.54
|
47,597
USD
|
|
|
2019-12-27 |
2019-12-26 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,923
-8.7%
78.52
150,987
USD
|
1,923
-8.7%
|
78.52
|
150,987
USD
|
|
|
2019-12-26 |
2019-12-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
6,114
-23.3%
78.54
480,166
USD
|
6,114
-23.3%
|
78.54
|
480,166
USD
|
|
|
2019-12-17 |
2019-12-16 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
5,735
-22.1%
78.62
450,886
USD
|
5,735
-22.1%
|
78.62
|
450,886
USD
|
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
16,766
-85.7%
78.72
1,319,742
USD
|
16,766
-85.7%
|
78.72
|
1,319,742
USD
|
|
|
2018-07-03 |
2018-07-02 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-30.5%
95.86
1,282,061
USD
|
13,375
-30.5%
|
95.86
|
1,282,061
USD
|
|
|
2018-06-04 |
2018-06-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-30.5%
92.21
1,233,326
USD
|
13,375
-30.5%
|
92.21
|
1,233,326
USD
|
|
|
2018-05-02 |
2018-05-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-23.2%
86.02
1,150,576
USD
|
13,375
-23.2%
|
86.02
|
1,150,576
USD
|
|
|
2018-04-04 |
2018-04-02 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
1,666
-100.0%
106.20
176,929
USD
|
1,666
-100.0%
|
106.20
|
176,929
USD
|
|
|
2018-04-04 |
2018-04-02 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-23.2%
103.52
1,384,583
USD
|
13,375
-23.2%
|
103.52
|
1,384,583
USD
|
|
|
2018-03-06 |
2018-03-05 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
15,428
-100.0%
99.04
1,527,968
USD
|
15,428
-100.0%
|
99.04
|
1,527,968
USD
|
|
|
2018-03-06 |
2018-03-05 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
22,875
-63.0%
99.05
2,265,698
USD
|
22,875
-63.0%
|
99.05
|
2,265,698
USD
|
|
|
2018-03-02 |
2018-03-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-31.2%
101.20
1,353,497
USD
|
13,375
-31.2%
|
101.20
|
1,353,497
USD
|
|
|
2018-02-02 |
2018-02-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-31.2%
99.20
1,326,765
USD
|
13,375
-31.2%
|
99.20
|
1,326,765
USD
|
|
|
2018-01-04 |
2018-01-03 |
S
Sale
|
Rubin Jonathan N
Chief Financial Officer
Officer
|
30,086
-53.2%
96.16
2,893,028
USD
|
30,086
-53.2%
|
96.16
|
2,893,028
USD
|
|
|
2018-01-03 |
2018-01-02 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,367
-31.2%
95.94
1,282,429
USD
|
13,367
-31.2%
|
95.94
|
1,282,429
USD
|
|
|
2018-01-03 |
2018-01-02 |
S
Sale
|
Rubin Jonathan N
Chief Financial Officer
Officer
|
17,443
-39.7%
96.07
1,675,782
USD
|
17,443
-39.7%
|
96.07
|
1,675,782
USD
|
|
|
2017-12-06 |
2017-12-04 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
2,180
-100.0%
92.00
200,560
USD
|
2,180
-100.0%
|
92.00
|
200,560
USD
|
|
|
2017-12-05 |
2017-12-04 |
S
Sale
|
Lewis Clapper Caskie
Chief Human Resources Officer
|
59,313
-76.3%
93.99
5,574,586
USD
|
59,313
-76.3%
|
93.99
|
5,574,586
USD
|
|
|
2017-12-04 |
2017-12-01 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
8,275
-38.1%
89.08
737,137
USD
|
8,275
-38.1%
|
89.08
|
737,137
USD
|
|
|
2017-11-02 |
2017-11-01 |
PS
Planned sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
9,369
-41.0%
89.20
835,751
USD
|
9,369
-41.0%
|
89.20
|
835,751
USD
|
|
|
2017-11-02 |
2017-11-01 |
PS
Planned sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1,154
-100.0%
92.00
106,168
USD
|
1,154
-100.0%
|
92.00
|
106,168
USD
|
|
|
2017-10-05 |
2017-10-04 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
2,475
-15.5%
88.10
218,048
USD
|
2,475
-15.5%
|
88.10
|
218,048
USD
|
|
|
2017-10-05 |
2017-10-04 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
5,000
-23.9%
88.00
440,000
USD
|
5,000
-23.9%
|
88.00
|
440,000
USD
|
|
|
2017-10-05 |
2017-10-03 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
5,000
-27.1%
88.00
440,000
USD
|
5,000
-27.1%
|
88.00
|
440,000
USD
|
|
|
2017-10-04 |
2017-10-03 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
30,021
-68.3%
87.31
2,621,242
USD
|
30,021
-68.3%
|
87.31
|
2,621,242
USD
|
|
|
2017-10-03 |
2017-10-02 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
19,007
-57.7%
86.22
1,638,689
USD
|
19,007
-57.7%
|
86.22
|
1,638,689
USD
|
|
|
2017-10-03 |
2017-09-29 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
18,511
-57.1%
86.18
1,595,317
USD
|
18,511
-57.1%
|
86.18
|
1,595,317
USD
|
|
|
2017-09-29 |
2017-09-28 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
4,848
-100.0%
85.76
415,782
USD
|
4,848
-100.0%
|
85.76
|
415,782
USD
|
|
|
2017-09-29 |
2017-09-28 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
25,316
-64.5%
85.85
2,173,452
USD
|
25,316
-64.5%
|
85.85
|
2,173,452
USD
|
|
|
2017-09-29 |
2017-09-27 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
1,419
-9.2%
86.06
122,125
USD
|
1,419
-9.2%
|
86.06
|
122,125
USD
|
|
|
2017-09-29 |
2017-09-27 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
18,502
-54.7%
85.24
1,577,131
USD
|
18,502
-54.7%
|
85.24
|
1,577,131
USD
|
|
|
2017-09-28 |
2017-09-27 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
35,658
-72.6%
85.17
3,036,928
USD
|
35,658
-72.6%
|
85.17
|
3,036,928
USD
|
|
|
2017-09-28 |
2017-09-27 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
600
-100.0%
86.06
51,635
USD
|
600
-100.0%
|
86.06
|
51,635
USD
|
|
|
2017-09-28 |
2017-09-27 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
18,526
-96.9%
85.31
1,580,373
USD
|
18,526
-96.9%
|
85.31
|
1,580,373
USD
|
|
|
2017-09-18 |
2017-09-15 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
2,402
-15.1%
83.00
199,366
USD
|
2,402
-15.1%
|
83.00
|
199,366
USD
|
|
|
2017-09-18 |
2017-09-15 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
2,961
-100.0%
84.00
248,724
USD
|
2,961
-100.0%
|
84.00
|
248,724
USD
|
|
|
2017-09-18 |
2017-09-14 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
18,063
-57.3%
83.05
1,500,163
USD
|
18,063
-57.3%
|
83.05
|
1,500,163
USD
|
|
|
2017-09-14 |
2017-09-13 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
585
-100.0%
83.00
48,555
USD
|
585
-100.0%
|
83.00
|
48,555
USD
|
|
|
2017-09-14 |
2017-09-13 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
14,096
-51.2%
83.06
1,170,883
USD
|
14,096
-51.2%
|
83.06
|
1,170,883
USD
|
|
|
2017-09-14 |
2017-09-12 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
19
-100.0%
83.00
1,577
USD
|
19
-100.0%
|
83.00
|
1,577
USD
|
|
|
2017-09-12 |
2017-09-11 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
670
-100.0%
83.00
55,610
USD
|
670
-100.0%
|
83.00
|
55,610
USD
|
|
|
2017-09-12 |
2017-09-11 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
2,400
-15.1%
83.00
199,200
USD
|
2,400
-15.1%
|
83.00
|
199,200
USD
|
|
|
2017-09-11 |
2017-09-08 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
6,267
-100.0%
81.53
510,918
USD
|
6,267
-100.0%
|
81.53
|
510,918
USD
|
|
|
2017-09-08 |
2017-09-07 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1,033
-100.0%
81.19
83,870
USD
|
1,033
-100.0%
|
81.19
|
83,870
USD
|
|
|
2017-09-08 |
2017-09-05 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1,157
-100.0%
80.96
93,669
USD
|
1,157
-100.0%
|
80.96
|
93,669
USD
|
|
|
2017-07-26 |
2017-07-25 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
4,559
-25.3%
80.68
367,820
USD
|
4,559
-25.3%
|
80.68
|
367,820
USD
|
|
|
2017-07-25 |
2017-07-24 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
32,398
-70.7%
80.12
2,595,582
USD
|
32,398
-70.7%
|
80.12
|
2,595,582
USD
|
|
|
2017-07-25 |
2017-07-21 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
1,176
-8.0%
80.02
94,102
USD
|
1,176
-8.0%
|
80.02
|
94,102
USD
|
|
|
2017-07-21 |
2017-07-20 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
16,073
-54.4%
80.06
1,286,751
USD
|
16,073
-54.4%
|
80.06
|
1,286,751
USD
|
|
|
2017-07-21 |
2017-07-20 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,109
-7.4%
80.01
88,728
USD
|
1,109
-7.4%
|
80.01
|
88,728
USD
|
|
|
2017-07-18 |
2017-07-17 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
600
-4.1%
80.10
48,060
USD
|
600
-4.1%
|
80.10
|
48,060
USD
|
|
|
2017-07-18 |
2017-07-14 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
27,914
-66.7%
80.07
2,234,940
USD
|
27,914
-66.7%
|
80.07
|
2,234,940
USD
|
|
|
2017-07-17 |
2017-07-14 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
14,114
-51.2%
80.11
1,130,685
USD
|
14,114
-51.2%
|
80.11
|
1,130,685
USD
|
|
|
2017-02-27 |
2017-02-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
100
-0.9%
82.10
8,210
USD
|
100
-0.9%
|
82.10
|
8,210
USD
|
|
|
2017-02-27 |
2017-02-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
100
-0.9%
81.05
8,105
USD
|
100
-0.9%
|
81.05
|
8,105
USD
|
|
|
2017-02-27 |
2017-02-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
100
-0.9%
80.00
8,000
USD
|
100
-0.9%
|
80.00
|
8,000
USD
|
|
|
2017-02-27 |
2017-02-23 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
300
-2.5%
81.12
24,335
USD
|
300
-2.5%
|
81.12
|
24,335
USD
|
|
|
2017-02-27 |
2017-02-23 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
12,912
-51.9%
80.28
1,036,516
USD
|
12,912
-51.9%
|
80.28
|
1,036,516
USD
|
|
